Protara Therapeutics, Inc. (TARA)
NASDAQ: TARA · Real-Time Price · USD
4.070
-0.030 (-0.73%)
Jul 20, 2026, 4:00 PM EDT - Market closed
Protara Therapeutics Market Cap
Protara Therapeutics has a market cap or net worth of $228.75 million as of July 21, 2026. Its market cap has increased by 92.50% in one year.
Market Cap
228.75M
Enterprise Value
54.38M
1-Year Change
92.50%
Ranking
Category
Stock Price
$4.07
ChartMarket Cap Chart
Since January 10, 2020, Protara Therapeutics's market cap has increased from $173.16M to $228.75M, an increase of 32.10%. That is a compound annual growth rate of 4.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 228.75M | -19.91% |
| Dec 31, 2025 | 285.62M | 12.67% |
| Dec 31, 2024 | 253.49M | 1,089.52% |
| Dec 29, 2023 | 21.31M | -29.43% |
| Dec 30, 2022 | 30.20M | -60.18% |
| Dec 31, 2021 | 75.84M | -72.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fulcrum Therapeutics | 243.21M |
| Cartesian Therapeutics | 242.69M |
| ProQR Therapeutics | 239.91M |
| Greenwich LifeSciences | 239.55M |
| Adagene | 237.20M |
| Compugen | 224.17M |
| Anavex Life Sciences | 221.49M |
| Nautilus Biotechnology | 221.12M |